Investigating RNA Off-Target Effects of FDA Approved Drugs to Understand Pharmacology
Time: 12:30 pm
day: Focus Day
Details:
- Small molecule screening reveals many drug-like compounds bind to RNA
- Using AI/ML to understand that many FDA approved drugs have RNA binding potential
- Transcriptome-wide binding and functional analysis reveals the impact of RNA binding on off-target pharmacology
